Abstract:AIM: To investigate the function and mechanism of miR-133a in gastric cancer (GC) and its relationship with clinicopathological characteristics of GC.METHODS: A total of 105 GC patients who underwent surgical resection as primary treatment were selected for this study. Real-time quantitative reverse transcriptase polymerase chain (qRT-PCR) was used to examine the expression levels of miR-133a in human GC and adjacent non-tumor tissues, as well as in GC cell lines (SGC-7901, BGC-823, MGC-803, and AGS) and a human gastric mucosal epithelial cell line (GES-1). The biological role of miRNA (miR)-133a was assessed in the GC cell lines using MTT, apoptosis, migration and invasion, and colony formation assays, and xenograft tumorigenesis. qRT-PCR and western blot analyses were used to evaluate the potential target gene expression of miR-133a. Pearson's correlation was calculated to evaluate the correlation between miR-133a and insulin-like growth factor 1 receptor (IGF1R) expression. The regulation of IGF1R by miR-133a was verified using the luciferase reporter assay.RESULTS: In 80% of the 105 GC patients, the mean expression of miR-133a was significantly downregulated in tumor tissues compared with adjacent normal tissues (1.215 +/- 0.1477 vs 3.093 +/- 0.4104, P < 0.0001). Downregulation of miR-133a was significantly correlated with the degree of differentiation (P = 0.01), local invasion (P = 0.001) and TNM stage (P = 0.02) in GC patients. Compared with a control construct, forced expression of miR-133a in GC cell lines inhibited proliferation (0.4787 +/- 0.0219 vs 0.7050 +/- 0.0147, P = 0.0013 in SGC-7901 cells; and 0.5448 +/- 0.0085 vs 0.7270 +/- 0.0084, P = 0.001 in MGC-803 cells); migration (0.6333 +/- 0.0233 vs 1.037 +/- 0.0584, P = 0.003 in SGC-7901 cells; 0.6126 +/- 0.0311 vs 1.024 +/- 0.0456, P = 0.0017 in MGC-803 cells); and invasion (0.613 +/- 0.0399 vs 1.033 +/- 0.0278, P = 0.0013 in SGC-7901 cells; 0.7433 +/- 0.0221 vs 1.017 +/- 0.0311, P = 0.002 in MGC-803 cells). It also induced apoptosis (18.19% +/- 0.2483% vs 5.887% +/- 0.3837%, P < 0.0001 in SGC-7901 cells; 22.69% +/- 0.7846% vs 9.347% +/- 0.3012%, P < 0.0001 in MGC-803 cells). Furthermore, miR-133a inhibited tumor growth and xenograft tumorigenesis of SGC -7901 cells in vivo. In addition, we identified IGF1R as a regulatory target of miR-133a in GC.CONCLUSION: This study suggests that miR-133a is downregulated in GC and functions as a tumor suppressor in vitro and in vivo partly by repressing IGF1R.

MiR-133b is frequently decreased in gastric cancer and its overexpression reduces the metastatic potential of gastric cancer cells

[Retracted] MicroRNA‑454 Inhibits Tumor Cell Proliferation, Migration and Invasion by Downregulating Zinc Finger E‑box‑binding Homeobox 1 in Gastric Cancer.

Mir-140-3p is Involved in the Occurrence and Metastasis of Gastric Cancer by Regulating the Stability of FAM83B

MiR-125b Promotes Cell Migration and Invasion by Targeting PPP1CA-Rb Signal Pathways in Gastric Cancer, Resulting in a Poor Prognosis

miR-133b Suppresses Invasion and Migration of Gastric Cancer Cells via the COL1A1/TGF-β Axis

Tumor Suppressor Role of Mir-133A in Gastric Cancer by Repressing IGF1R.

MiR-375 Frequently Downregulated in Gastric Cancer Inhibits Cell Proliferation by Targeting JAK2

Decreased Expression Of Mir-378 Is Associated With Local Invasion, Lymph Node Metastasis And Poor Prognosis In Gastric Cancer

Mir-199A-3p Targets ETNK1 to Promote Invasion and Migration in Gastric Cancer Cells and is Associated with Poor Prognosis.

Mir-145, Mir-133a and Mir-133b Inhibit Proliferation, Migration, Invasion and Cell Cycle Progression Via Targeting Transcription Factor Sp1 in Gastric Cancer

Mir-129-5p Attenuates Cell Proliferation and Epithelial Mesenchymal Transition Via HMGB1 in Gastric Cancer

Mir-337-3p Inhibits Gastric Tumor Metastasis by Targeting ARHGAP10

MiR-181d Inhibits Cell Proliferation and Metastasis Through PI3K/AKT Pathway in Gastric Cancer.

Loss of Has-Mir-337-3p Expression is Associated with Lymph Node Metastasis of Human Gastric Cancer

MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis

MicroRNA-206 suppresses gastric cancer cell growth and metastasis

The Downregulation of Mir-200C/141 Promotes ZEB1/2 Expression and Gastric Cancer Progression

MiR-140-3p Impedes Gastric Cancer Progression and Metastasis by Regulating BCL2/BECN1-Mediated Autophagy

Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer.

Mir-373 Suppresses Gastric Cancer Metastasis by Downregulating Vimentin.

miR-22 is down-regulated in gastric cancer, and its overexpression inhibits cell migration and invasion via targeting transcription factor Sp1